TORONTO, ONTARIO — (Marketwire) — 05/07/12 — Attention: Business/Financial Editors
The Medipattern Corporation (“Medipattern” or the “Company”) (TSX VENTURE: MKI), announced today that SonoCare, LLC (“SonoCare”) has received Visualize:Vascular and will begin offering the 3D visualization procedure to patients through its 53 mobile sites serving communities in North and South Carolina. SonoCare brings cutting edge mobile imaging technology directly to the physician-s office and direct to patients in residential settings. Their highly qualified and experienced sonographers offer Ultrasound imaging services to patients in the convenience and comfort of familiar surroundings. SonoCare is dedicated to providing courteous, thorough, and compassionate patient care of the highest quality with uncompromised results and outstanding service. SonoCare is one of the few companies in the Carolina-s that is accredited by the Intersocietal Commission for the Accreditation of Echocardiography Laboratories (“ICAEL”). This was achieved because of their commitment to quality patient care.
“We are very pleased to be the first vascular imaging company to offer Visualize:Vascular in the Southeastern United States,” stated Mark Schubring, Clinical Director of SonoCare. “Carotid artery disease (“CAD”) is a major concern in our communities. SonoCare performs a significant number of carotid duplex exams and screenings each month to identify patients that may benefit from additional medical attention. We believe that this 3D technology for ultrasound will give us an edge for patients who are difficult to image.”
“SonoCare brings state of the art ultrasound imaging technology and certified sonographers to the doctor-s offices that they serve. Their outstanding American College of Radiology (“ACR”) accredited program ensures exceptional patient care. Installation and training are expected to be completed by the end of this quarter as each site is phased in,” stated Jeff Collins, CEO The Medipattern Corporation. “We continue to grow our installed base and scanning volume is expected to continue to grow as we roll out our software throughout the Southeastern United States. We are very pleased to work with SonoCare and support their commitment to quality imaging procedures.”
Upcoming Events
Annual Meeting – MHA June 6 – 7, 2012 Brewster, MA
SVU/SVS Annual Conference June 7 – 9, 2012 Baltimore, MD
About the Medipattern Corporation:
Medipattern® is a pioneer in the development of imaging software solutions that help medical practitioners to better understand lesions and critical anatomy. Medipattern uses its Cadenza technology to process images, finding the salient region of interest and presenting them in 2D and 3D formats that enhance the reader-s perception. For more information, please visit the Company-s website: .
Medipattern® is a registered trademark of The Medipattern Corporation. Cadenza is a trademark of the Medipattern Corporation. SonoCine® is a registered trademark of SonoCine, Inc.
Forward-looking statements
This document contains forward-looking statements relating to Medipattern-s performance, operations, or business environment. These statements are based on what we believe are reasonable assumptions given currently available information and our understanding of Medipattern-s current activities. We have tried, whenever possible, to identify these forward-looking statements using words such as “anticipates,– “believes,– “estimates,– “expects,– “plans,– “intends,– “potential–, and similar expressions. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict or control. A number of factors could cause actual outcomes and results to differ materially from those expressed in forward-looking statements. These factors include but are not limited to those set forth in the Company-s corporate filings, (posted at ). In addition, these forward-looking statements relate to the date on which they are made. The Company disclaims any intention or obligation to update or revise any forward-looking statements for any reason. Readers should not rely on forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contacts:
The Medipattern Corporation
Jeff Collins
CEO
(416) 744-0009 ext. 224
Spinnaker Capital Markets Inc.
Kevin O-Connor
(416) 962-3300 ext. 226
You must be logged in to post a comment Login